1. Good manufacturing practice guide for active pharmaceutical ingredients, Q7, in ICH harmonized triparitte guidline, 2000, International conference on harmonization.
2. Validation of cleaning processes (7/93). Guide to inspections validation of celaning procesees, U.S.F.a.D. Admistration, Editor, 2004.
3. U.S. Department of Health and Human Services, F., Warning Letter: 320-12-08, Gulf Pharmaceuticals, 2012.
4. U.S. Department of Health and Human Services, F., Warning letter: 320-12-058, Novartis International AG, 2011.
5. U.S. Department of Health and Human Services, F., Warning Letter: 05-10, Teva Parenterals Medicines, Inc. 2009.